Chitnis T, Arnold DL, Quartier P, Chirieac M, et al. Safety, efficacy, and tolerability of alemtuzumab in pediatric patients with active relapsing-remitting multiple sclerosis: The LemKids study. Mult Scler 2024 Dec 1:13524585241295554. doi: 10.1177/13524585241295554.
PMID: 39618059